3 month dutasteride mesotherapy (3 session) . Minoxidil 2.5 month ( changed the brand 25 days ago) / ketoconazol shampoo 5/16/2026
The user is experiencing significant hair shedding after 3 months of dutasteride mesotherapy, 2.5 months of Minoxidil, and using ketoconazole shampoo. They are concerned about the shedding but plan to continue the treatment.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Dutasteride + oral minoxidil: strong regrowth by Jan 2026, then mid-scalp density loss without current shedding
The user experienced hair regrowth with dutasteride and oral minoxidil from October 2025 to January 2026, but mid-scalp density decreased afterward despite continued treatment. Ketoconazole improves scalp condition, but stopping it worsens hair appearance.
community 24M – aggressive shedding, past success with mesotherapy + minoxidil, now worse than before. Unsure if I should try a combo or consider a transplant.
A 24-year-old is experiencing aggressive hair shedding despite past success with mesotherapy and minoxidil, and is considering adding treatments like Expecia, dermapen, or a hair transplant. Many suggest using finasteride to maintain hair, as it is necessary even after a transplant, and side effects are rare and reversible.
community FTM/NB Hairloss from HRT, treatment started and feeling hopeless.
A non-binary individual experienced hair loss after stopping hormone replacement therapy and is using oral Dutasteride, oral Minoxidil, and ketoconazole shampoo. They are hopeful for regrowth but may use wigs due to the high cost and uncertain effectiveness of additional treatments like mesotherapy and PRP.
community 2.5 Years Dutasteride Monotherapy Before and After
The user shared progress pictures after 2.5 years of using 0.5mg daily Dutasteride for hair loss, noting a significant increase in hair density and cosmetic changes to improve appearance. They avoided Minoxidil due to hassle and side effects, and plan to consider a hair transplant in the future.
community Any treatment not nuking systemic DHT levels?
Hair loss treatments that avoid significantly lowering systemic DHT levels, focusing on topical options like dutasteride mesotherapy, minoxidil, and ketoconazole. The user is exploring alternatives like KX-826 and RU58841 due to concerns about hormone levels.
Related Research
6 / 6 resultsresearch Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
research Interventions for female pattern hair loss
This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
research Analysis of Female Pattern Hair loss
This article discusses female pattern baldness and effective treatments like oral anti-androgens and topical minoxidil for managing its progression and reversing hair follicle shrinkage, but reports no new findings.
research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.
research Hair Loss in Women
This article presents a systematic approach for obstetricians/gynecologists to diagnose and manage common types of nonscarring hair loss in women, reporting no new clinical results.